ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: L09

A Prediction Model to Distinguish Patients with Multisystem Inflammatory Syndrome in Children

Matthew Clark1, Danielle Rankin2, Alisa Gotte1, Alison Herndon1, William McEachern1, Andrew Smith3, Daniel Clark1, Edward Hardison1, Anna Patrick1, Lauren Peetluk1, Natasha Halasa1, James Connelly1 and Sophie Katz1, 1Vanderbilt University Medical Center, Nashville, TN, 2Vanderbilt University, Nashville, TN, 3The Heart Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL

Meeting: ACR Convergence 2021

Date of first publication: October 22, 2021

Keywords: COVID-19, Late-Breaking 2021, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Late-Breaking Posters (L01 - L15)

Session Type: Poster Session D

Background/Purpose: Multisystem inflammatory syndrome in children (MIS-C) is a rare consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MIS-C shares features with common infectious and inflammatory syndromes, and differentiation early in the disease course can be difficult. We aimed to develop a diagnostic prediction model using clinical, laboratory, and cardiac features within the first 24 hours of presentation to distinguish  children with MIS-C from those with alternative diagnoses.

Methods: Data were obtained by retrospective chart review of children (≤20 years) admitted to Vanderbilt Children’s Hospital and evaluated for MIS-C using our institutional algorithm between June 10, 2020 – April 8, 2021. Standardized clinical, laboratory, and cardiac characteristics were collected on each child during the first 24 hours of hospital presentation. Our outcome was defined as clinically diagnosed MIS-C, which was determined by the child’s primary service and retrospectively reviewed and confirmed by both a Pediatric Rheumatologist and Pediatric Infectious Disease physician. Candidate predictors were selected a priori and were examined for collinearity Spearman correlations. Logistic regression with bootstrapped backward selection was used to identify the most important predictors for MIS-C. Variables selected in ≥80% of 500 bootstraps were included in the final model. Discrimination was quantified with C-index and calibration was assessed using a calibration plot. Internal validation with bootstrap resampling was used to estimate optimism-corrected performance measures.

Results: During the study period, 127 children were admitted to our hospital with concern and evaluation for MIS-C. We identified clinical, lab, and cardiac features that distinguished those with MIS-C (n=45) from those without (n=82). We used statistically distinct variables to build a risk prediction model. Four predictors were included in our final model: hypotension (defined as requiring fluid resuscitation, vasopressor support or blood pressure less than 10th percentile for age, height and sex), abdominal pain, rash, and serum sodium (mmol/L). The model showed excellent discrimination with c-index of 0.90 (95% CI: 0.85, 0.94; Figure 1). The model has good calibration but has slight departure between 20-40% probability (optimism-corrected slope: 0.93; optimism-corrected intercept: -0.04; Figure 2).

Conclusion: We used early clinical and laboratory features to inform the design of a clinical diagnostic prediction model with excellent discrimination to assist clinicians in distinguishing patients with MIS-C from those without. We plan to test this model with external and prospective validation.

Figure 1: Receiver Operating Characteristic Curve Measuring Discrimination Measures of MIS-C versus Non-MIS-C

Figure 2: Calibration Plot of Observed and Predicted Outcome Probabilities


M. Clark, None; D. Rankin, None; A. Gotte, None; A. Herndon, None; W. McEachern, None; A. Smith, None; D. Clark, None; E. Hardison, None; A. Patrick, None; L. Peetluk, None; N. Halasa, None; J. Connelly, X4 Pharmaceuticals, 1, Horizon Therapeutics, 1; S. Katz, None.

To cite this abstract in AMA style:

Clark M, Rankin D, Gotte A, Herndon A, McEachern W, Smith A, Clark D, Hardison E, Patrick A, Peetluk L, Halasa N, Connelly J, Katz S. A Prediction Model to Distinguish Patients with Multisystem Inflammatory Syndrome in Children [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-prediction-model-to-distinguish-patients-with-multisystem-inflammatory-syndrome-in-children/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-prediction-model-to-distinguish-patients-with-multisystem-inflammatory-syndrome-in-children/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology